Stay updated with the latest in Tech, Science, Culture, Entertainment, and more by following our Telegram channel here.
A new study conducted in Israel has shown that a variant of the coronavirus that was first identified in South Africa may have the capability to bypass the protection offered by the Pfizer-BioNTech vaccine.
The study – which is yet to be peer-reviewed – was conducted by scientists at the Tel Aviv University and Clalit, Israel’s largest healthcare…